Literature DB >> 11026929

Drug-induced liver disease.

J H Lewis1.   

Abstract

The incidence of drug-induced liver disease appears to be increasing, reflecting the increasing number of new agents that have been introduced into clinical use over the past several decades. Among the topics covered, the author discusses incidence, diagnosis, risk factors, clinical presentations, hepatitis, and vascular injury. The author also reviews the hepatic injury seen with commonly prescribed drugs, emphasizing newer developments in the field and recent publications and reports.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11026929     DOI: 10.1016/s0025-7125(05)70287-x

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  21 in total

1.  Mellow Yellow: Diagnosis and Management of Multifactorial Postoperative Jaundice.

Authors:  Apurva Tandon; Andrew K Roorda; Prithvi Legha; Ankur Sangoi; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2015-10-30       Impact factor: 3.199

Review 2.  Drug-induced cholestasis.

Authors:  Manmeet S Padda; Mayra Sanchez; Abbasi J Akhtar; James L Boyer
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

Review 3.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

Review 4.  Hepatic findings in long-term clinical trials of ximelagatran.

Authors:  William M Lee; Dominique Larrey; Rolf Olsson; James H Lewis; Marianne Keisu; Laurent Auclert; Sunita Sheth
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  Drug-induced liver injury in the elderly.

Authors:  Jonathan G Stine; Praveen Sateesh; James H Lewis
Journal:  Curr Gastroenterol Rep       Date:  2013-01

6.  Alverine citrate induced acute hepatitis.

Authors:  Mehmet Arhan; Seyfettin Koklu; Aydln-S Koksal; Omer-F Yolcu; Senem Koruk; Irfan Koruk; Ertugrul Kayacetin
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

7.  Value of preapproval safety data in predicting postapproval hepatic safety and assessing the legitimacy of class warning.

Authors:  Yeong-Liang Lin; Ya-Chi Wu; Churn-Shiouh Gau; Min-Shung Lin
Journal:  Ther Adv Drug Saf       Date:  2012-02

Review 8.  Over-the-counter analgesics in older adults: a call for improved labelling and consumer education.

Authors:  Christianne L Roumie; Marie R Griffin
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 9.  Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.

Authors:  Jonathan G Stine; James H Lewis
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-25       Impact factor: 3.869

Review 10.  Management of drug-induced liver disease.

Authors:  G Marino; H J Zimmerman; J H Lewis
Journal:  Curr Gastroenterol Rep       Date:  2001-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.